IL160785A0 - Tetrahydropyran derivatives and their use as therapeutic agents - Google Patents
Tetrahydropyran derivatives and their use as therapeutic agentsInfo
- Publication number
- IL160785A0 IL160785A0 IL16078502A IL16078502A IL160785A0 IL 160785 A0 IL160785 A0 IL 160785A0 IL 16078502 A IL16078502 A IL 16078502A IL 16078502 A IL16078502 A IL 16078502A IL 160785 A0 IL160785 A0 IL 160785A0
- Authority
- IL
- Israel
- Prior art keywords
- sup
- sub
- therapeutic agents
- replaced
- hydrogen atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0121874.2A GB0121874D0 (en) | 2001-09-10 | 2001-09-10 | Therapeutic agents |
| PCT/GB2002/004085 WO2003022839A1 (en) | 2001-09-10 | 2002-09-06 | Tetrahydropyran derivatives and their use as therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL160785A0 true IL160785A0 (en) | 2004-08-31 |
Family
ID=9921835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16078502A IL160785A0 (en) | 2001-09-10 | 2002-09-06 | Tetrahydropyran derivatives and their use as therapeutic agents |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7265110B2 (de) |
| EP (1) | EP1427723B1 (de) |
| JP (1) | JP2005506329A (de) |
| KR (1) | KR20040045435A (de) |
| CN (1) | CN1578778A (de) |
| AT (1) | ATE328881T1 (de) |
| BR (1) | BR0212454A (de) |
| CA (1) | CA2459464A1 (de) |
| DE (1) | DE60212153T2 (de) |
| ES (1) | ES2263803T3 (de) |
| GB (1) | GB0121874D0 (de) |
| IL (1) | IL160785A0 (de) |
| MX (1) | MXPA04002295A (de) |
| NO (1) | NO20041431L (de) |
| PL (1) | PL368208A1 (de) |
| RU (1) | RU2004110950A (de) |
| WO (1) | WO2003022839A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0121874D0 (en) | 2001-09-10 | 2001-10-31 | Merck Sharp & Dohme | Therapeutic agents |
| GB0217068D0 (en) * | 2002-07-23 | 2002-08-28 | Merck Sharp & Dohme | Therapeutic agents |
| AU2004218228A1 (en) * | 2003-03-07 | 2004-09-16 | Merck Sharp & Dohme Limited | Tetrahydropyran compounds as tachykinin antagonists |
| US11773127B2 (en) * | 2017-11-08 | 2023-10-03 | Washington University | Compounds and methods for treating bacterial infections |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0906315A1 (de) * | 1996-06-21 | 1999-04-07 | MERCK SHARP & DOHME LTD. | Spiro-piperdin-derivate und ihre verwendung als therapeutica |
| CO5150225A1 (es) * | 1999-03-19 | 2002-04-29 | Merck Sharp & Dohme | Derivados del tetrahidropirano y su uso como agentes terapeuticos |
| GB0020721D0 (en) * | 2000-08-22 | 2000-10-11 | Merck Sharp & Dohme | Therapeutic agents |
| GB0121874D0 (en) | 2001-09-10 | 2001-10-31 | Merck Sharp & Dohme | Therapeutic agents |
-
2001
- 2001-09-10 GB GBGB0121874.2A patent/GB0121874D0/en not_active Ceased
-
2002
- 2002-09-06 MX MXPA04002295A patent/MXPA04002295A/es not_active Application Discontinuation
- 2002-09-06 RU RU2004110950/04A patent/RU2004110950A/ru not_active Application Discontinuation
- 2002-09-06 CA CA002459464A patent/CA2459464A1/en not_active Abandoned
- 2002-09-06 EP EP02755343A patent/EP1427723B1/de not_active Expired - Lifetime
- 2002-09-06 DE DE60212153T patent/DE60212153T2/de not_active Expired - Lifetime
- 2002-09-06 JP JP2003526914A patent/JP2005506329A/ja not_active Ceased
- 2002-09-06 WO PCT/GB2002/004085 patent/WO2003022839A1/en not_active Ceased
- 2002-09-06 US US10/488,842 patent/US7265110B2/en not_active Expired - Fee Related
- 2002-09-06 AT AT02755343T patent/ATE328881T1/de not_active IP Right Cessation
- 2002-09-06 BR BR0212454-8A patent/BR0212454A/pt not_active Application Discontinuation
- 2002-09-06 IL IL16078502A patent/IL160785A0/xx unknown
- 2002-09-06 KR KR10-2004-7003573A patent/KR20040045435A/ko not_active Withdrawn
- 2002-09-06 ES ES02755343T patent/ES2263803T3/es not_active Expired - Lifetime
- 2002-09-06 CN CNA028214706A patent/CN1578778A/zh active Pending
- 2002-09-06 PL PL02368208A patent/PL368208A1/xx not_active Application Discontinuation
-
2004
- 2004-04-06 NO NO20041431A patent/NO20041431L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2004110950A (ru) | 2005-04-10 |
| MXPA04002295A (es) | 2004-06-18 |
| EP1427723B1 (de) | 2006-06-07 |
| EP1427723A1 (de) | 2004-06-16 |
| KR20040045435A (ko) | 2004-06-01 |
| US7265110B2 (en) | 2007-09-04 |
| CA2459464A1 (en) | 2003-03-20 |
| JP2005506329A (ja) | 2005-03-03 |
| ES2263803T3 (es) | 2006-12-16 |
| DE60212153T2 (de) | 2007-05-24 |
| ATE328881T1 (de) | 2006-06-15 |
| US20040254184A1 (en) | 2004-12-16 |
| PL368208A1 (en) | 2005-03-21 |
| WO2003022839A1 (en) | 2003-03-20 |
| BR0212454A (pt) | 2004-10-19 |
| CN1578778A (zh) | 2005-02-09 |
| DE60212153D1 (de) | 2006-07-20 |
| NO20041431L (no) | 2004-06-01 |
| GB0121874D0 (en) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL176107A0 (en) | Azabicyclic heterocycles as cannabinoid receptor modulators | |
| IL176110A0 (en) | Azabicyclic heterocycles as cannabinoid receptor modulators | |
| NO20083114L (no) | Polysykliske indazolderivater som er ERK-inhibitorer | |
| TW200726765A (en) | Triazolopyridine cannabinoid receptor 1 antagonists | |
| SG159380A1 (en) | Heteroaryl compounds useful as inhibitors of gsk-3 | |
| DE60315674D1 (de) | Neue imidazopyridine und ihre verwendung | |
| PL369108A1 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| MXPA00006605A (es) | Compuestos de carbonil-indol biciclicos como agentes antiinflamatorios/analgesicos. | |
| AU2003228674A1 (en) | Muscarinic antagonists | |
| AU3304400A (en) | Tetrahydropyran derivatives and their use as therapeutic agents | |
| GB0314967D0 (en) | Piperazine derivatives | |
| SG165162A1 (en) | Modified release pharmaceutical formulation | |
| NO20055655D0 (no) | Anvendelse av azetidinkarboksamidderivater i terapi | |
| WO2005046672A3 (fr) | Utilisation d’inhibiteurs de glucosidase pour une therapie de la mucoviscidose | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| SE0102055D0 (sv) | New Compounds | |
| NO20052182L (no) | Nye forbindelser | |
| NO20062255L (no) | 4-anilino-3-kinolinkarbonitriler for behandling av kronisk myelogenos leukemi (CML) | |
| TW200420292A (en) | Benzofuran derivative | |
| UA97483C2 (ru) | Производное пиримидина в качестве ингибитора pi3k и его применение | |
| JO2231B1 (en) | Derivatives of Trahydroperan and its use as a therapeutic agent | |
| MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
| IL160785A0 (en) | Tetrahydropyran derivatives and their use as therapeutic agents | |
| WO2005053702A3 (en) | Anti-inflammatory agents | |
| ATE411311T1 (de) | Tetrahydropyranverbindungen als tachykininantagonisten |